Clinical activity of bintrafusp alfa was noted in patients with a range of prior treatments and treatment responses and irrespective of tumor PD-L1 expression that was obtained from fresh baseline tumor tissue (Figs. 1-3 and Supplementary Fig. SA.1). Here, CD274 is linked to neoplasm.